Navidea生物制药(NAVB)

1.70 -0.02 -1.1628%

今开:1.69昨收:1.72
最高:1.76 最低:1.69
涨停价:0.0跌停价:0.0
总市值:4.93432E7

Navidea生物制药的热门评论

Navidea生物制药(NAVB)2019-05-10 10:05

$Navidea生物制药(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-09 AccNo: 0001437749-19-009295 Size: 5 MB 网页链接查看全文

Navidea生物制药(NAVB)2019-04-27 10:25

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-04-26 AccNo: 0001437749-19-008036 Size: 31 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Stateme...查看全文

Navidea生物制药(NAVB)2019-04-25 07:30

$Navidea生物制药(NAVB)$ 美东时间 2019-04-26 拆合股: 20合1 网页链接查看全文

Navidea生物制药(NAVB)2019-04-20 11:10

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-04-19 AccNo: 0001437749-19-007613 Size: 42 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 3.03: Material Modifications to Rights of Security HoldersI...查看全文

Navidea生物制药(NAVB)2019-04-09 10:30

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-04-08 AccNo: 0001437749-19-006744 Size: 48 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 9.01: Financial Statements and Exhibits 网页链接查看全文

汇众医疗2019-04-09 14:29

【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13% $Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文

Navidea生物制药(NAVB)2019-03-25 23:55

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-03-25 AccNo: 0001437749-19-005549 Size: 40 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Navidea生物制药(NAVB)2019-03-26 08:45

$Navidea生物制药(NAVB)$ 内部交易: 2019-03-22,10% Owner,Scott John K Jr. ,买入,357143普通股, $0.14查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Navidea生物制药的最新评论

持股变动声明

Navidea生物制药(NAVB)07-27 21:03

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-017568 Size: 4 KB 网页链接查看全文

Navidea生物制药(NAVB)07-27 07:33

$Navidea生物制药(NAVB)$ 内部交易: 2021-07-26,Director,Witter Malcolm G ,买入,15000普通股, $1.70查看全文

首次持股声明

Navidea生物制药(NAVB)07-14 06:42

$Navidea生物制药(NAVB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-016871 Size: 2 KB 网页链接查看全文

当期报告

Navidea生物制药(NAVB)07-14 04:21

$Navidea生物制药(NAVB)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001437749-21-016842 Act: 34 Size: 59 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)07-08 06:00

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-016596 Size: 4 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)07-08 06:00

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-016598 Size: 4 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)07-08 06:00

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-016600 Size: 4 KB 网页链接查看全文

当期报告

Navidea生物制药(NAVB)06-25 04:57

$Navidea生物制药(NAVB)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-21-015554 Act: 34 Size: 36 KB 网页链接查看全文

Navidea生物制药(NAVB)06-15 23:51

$Navidea生物制药(NAVB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-21-081310 Act: 34 Size: 54 KB 网页链接查看全文

Navidea生物制药(NAVB)05-25 18:06

$Navidea生物制药(NAVB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-002085 Act: 33 Size: 1 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Navidea生物制药的公告

持股变动声明

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-017568 Size: 4 KB 网页链接

$Navidea生物制药(NAVB)$ 内部交易: 2021-07-26,Director,Witter Malcolm G ,买入,15000普通股, $1.70

首次持股声明

$Navidea生物制药(NAVB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-016871 Size: 2 KB 网页链接

当期报告

$Navidea生物制药(NAVB)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001437749-21-016842 Act: 34 Size: 59 KB 网页链接

持股变动声明

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-016596 Size: 4 KB 网页链接

持股变动声明

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-016598 Size: 4 KB 网页链接

持股变动声明

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-016600 Size: 4 KB 网页链接

当期报告

$Navidea生物制药(NAVB)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-21-015554 Act: 34 Size: 36 KB 网页链接

$Navidea生物制药(NAVB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-21-081310 Act: 34 Size: 54 KB 网页链接

$Navidea生物制药(NAVB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-002085 Act: 33 Size: 1 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32